Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10595577 | Bioorganic & Medicinal Chemistry Letters | 2013 | 4 Pages |
Abstract
The biological activities of six symmetrically substituted 2-methoxy-benzyl polymethylene tetraamines (1-4) and diphenylethyl polymethylene tetraamines (5 and 6) as N-methyl-d-aspartate (NMDA) receptor channel blockers, were evaluated in vitro and in vivo. Although all compounds exhibited stronger channel block activities in comparison to memantine in Xenopus oocytes voltage clamped at â70Â mV, only compound 2 (0.4Â mg/kg intravenous injection) decreased the size of brain infarction in a photochemically induced thrombosis model mice at the same extent of memantine (10Â mg/kg intravenous injection). Other compounds (1, 3, 4, 5 and 6) did not decrease the size of brain infarction significantly due to the limited injection doses. The present study suggests that compound 2 could represent a valuable lead compound to design low toxicity polyamines for clinical use against stroke.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Ryotaro Saiki, Yuki Yoshizawa, Anna Minarini, Andrea Milelli, Chiara Marchetti, Vincenzo Tumiatti, Toshihiko Toida, Keiko Kashiwagi, Kazuei Igarashi,